Apimeds Pharmaceuticals US (APUS) Enterprise Value: 13.26M

Apimeds Pharmaceuticals US, Inc. (APUS)

4.55 -0.07 (-1.52%) USD | NYAM | Oct 14, 11:41

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2025. Start Trial.

Date	Value
October 13, 2026	13.26M
October 12, 2026	14.14M
October 09, 2026	13.87M
October 08, 2026	14.61M
October 07, 2026	16.93M
October 06, 2026	17.05M
October 05, 2026	13.22M
October 02, 2026	11.15M
October 01, 2026	12.48M
September 30, 2026	13.84M
September 29, 2026	13.87M
September 28, 2026	15.93M
September 25, 2026	17.23M
September 24, 2026	13.72M
September 23, 2026	9.747M
September 22, 2026	9.083M
September 21, 2026	8.811M
September 18, 2026	8.962M
September 17, 2026	8.811M
September 16, 2026	8.705M
September 15, 2026	8.766M
September 14, 2026	9.445M
September 11, 2026	9.468M
September 10, 2026	9.566M
September 09, 2026	9.747M

Date	Value
September 08, 2026	9.762M
September 04, 2026	9.943M
September 03, 2026	10.08M
September 02, 2026	10.26M
September 01, 2026	11.63M
August 31, 2026	12.15M
August 28, 2026	12.13M
August 27, 2026	12.25M
August 26, 2026	13.23M
August 25, 2026	13.79M
August 24, 2026	13.46M
August 21, 2026	13.59M
August 20, 2026	12.92M
August 19, 2026	12.92M
August 18, 2026	12.33M
August 17, 2026	12.75M
August 14, 2026	13.16M
August 13, 2026	13.38M
August 12, 2026	13.32M
August 11, 2026	13.28M
August 10, 2026	12.69M
August 07, 2026	12.67M
August 06, 2026	13.58M
August 05, 2026	13.31M
August 04, 2026	13.72M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks